Biochemistry, Genetics and Molecular Biology
Methylenetetrahydrofolate Reductase
100%
Hemodialysis
100%
Genotyping
66%
Gene Frequency
54%
Feeder Cell
50%
Mean Corpuscular Volume
50%
Hematopoiesis
50%
Codon
50%
Apolipoprotein E
50%
TLR4
50%
NOD2
50%
Prevalence
50%
Deficiency
50%
Allele
50%
Gene Polymorphism
50%
Glycoprotein IIb/IIIa
50%
Induced Pluripotent Stem Cell
41%
Cas9
33%
Gene Flow
25%
Gene Flow
25%
CD34
25%
Reprogramming
25%
CRISPR/Cas9
25%
Mutagenesis
25%
Hematopoietic Cell
25%
Homozygosity
25%
Human Induced Pluripotent Stem Cell
25%
Point Mutation
25%
Stem Cell
25%
Restriction Fragment Length Polymorphism
20%
Somatic Cell
20%
Splice Site Mutation
16%
Genetic Susceptibility
16%
Protospacer Adjacent Motif
16%
Nucleobase
16%
Homocysteine
12%
Polymerase Chain Reaction
12%
Genetics
12%
Homozygote
8%
Platelet Glycoprotein IIb/IIIa
8%
Transposable Element
8%
Promoter Region
8%
Globin Gene
8%
Binding Site
8%
Guide RNA
8%
Hemoglobin A
5%
Allele-Specific Oligonucleotide
5%
Blood Sampling
5%
Neuroscience
Allele Frequency
56%
Inflammatory Bowel Disease
50%
Hemoglobin A2
50%
Codon
50%
DNA Polymorphism
50%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
50%
Fibrinogen Receptor
50%
TLR 4
25%
Risk Factor
22%
Restriction Fragment Length Polymorphism
22%
Somatic Cell
20%
Myocardial Infarction
16%
Homocysteine
12%
Platelet
8%
Promoter Region
6%
Enzyme Activity
6%
Polymerase Chain Reaction
6%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
66%
Fibrinogen Receptor
50%
Mutagenesis
50%
Combination Therapy
50%
Beta Thalassemia
50%
Thalassemia
50%
Prevalence
25%
End Stage Renal Disease
25%
Hemodialysis
25%
Hemoglobin Beta Chain
16%
Positive Allosteric Modulator
16%
Nucleic Acid Base
16%
Binding Site
16%
Hemoglobin A2
12%
Kidney Allograft Rejection
8%
Heart Infarction
8%
Kidney Disease
8%
